Canada
12 Vaccines Approved for Use in Canada
Protein Subunit
Novavax
Nuvaxovid
Approved in 40 countries
22 trials in 14 countries
Approval Source: covid-vaccine.canada.ca
VLP
RNA
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Approval Source: canada.ca
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: canada.ca
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Approval Source: covid-vaccine.canada.ca
Non Replicating Viral Vector
Serum Institute of India
Covishield (Oxford/ AstraZeneca formulation)
Approved in 49 countries
6 trials in 1 country
Approval Source: theglobeandmail.com
RNA
Moderna
Spikevax Bivalent Original/Omicron BA.1
Approved in 38 countries
5 trials in 4 countries
Approval Source: ctvnews.ca
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
Approval Source: canada.ca
RNA
Moderna
Spikevax Bivalent Original/Omicron BA.4/BA.5
Approved in 33 countries
2 trials in 1 country
Approval Source: cbc.ca
RNA
Pfizer/BioNTech
Comirnaty Bivalent Original/Omicron BA.1
Approved in 35 countries
3 trials in 5 countries
Approval Source: canada.ca
RNA
Pfizer/BioNTech
Comirnaty Bivalent Original/Omicron BA.4/BA.5
Approved in 33 countries
4 trials in 1 country
Approval Source: ctvnews.ca
14 in Clinical Trials in Canada
Protein Subunit
Novavax
Nuvaxovid
Approved in 40 countries
22 trials in 14 countries
VLP
Medicago
Covifenz
Approved in 1 country
6 trials in 6 countries
RNA
Moderna
Spikevax
Approved in 88 countries
70 trials in 24 countries
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Protein Subunit
University of Saskatchewan
COVAC-2
5 trials in 2 countries
VLP
VBI Vaccines Inc
VBI-2902a
2 trials in 1 country
DNA
Entos Pharmaceuticals Inc
Covigenix VAX-001
2 trials in 1 country
RNA
Providence Therapeutics Holdings Inc.
PTX-COVID19-B
4 trials in 2 countries
Protein Subunit
University of Saskatchewan
COVAC-1
Non Replicating Viral Vector
McMaster University
Ad5-triCoV/Mac
Non Replicating Viral Vector
McMaster University
ChAd-triCoV/Mac
VLP
VBI Vaccines Inc
VBI-2901a
VLP
VBI Vaccines Inc.